SPL-707

N/A

Report date: 2024/11/12 15:24:04
NME

Base Information

Drug NameSPL-707
Drug Alias NameSPL-707
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal peptide peptidase-like 2A inhibitors
TargetsSignal peptide peptidase-like 2A
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A